Femarelle Rejuvenate Pre-Menopause Relief for Mood, Skin, Fatigue & More. Clinically Shown to Relieve Menopausal Symptoms -1 Month Supply

style:

Rejuvenate

Retail Price: $ 30.9

Wholesale Price: Inquire Now

Femarelle is the most recommended non-hormonal option, endorsed by leading gynecologists around the world. Backed by science and sales of millions of units to date, the Femarelle line provides women around the globe a safe and effective option to alleviate their menopausal symptoms.

Rejuvenate

1 Pack (56 Capsules) = 4 Weeks Supply

If you are in your 40s, and you start to see changes in your regular menstruation patterns, Femarelle Rejuvenate is for you.

Femarelle Rejuvenate targets the primary stages and symptoms that accompany the hormonal changes that start in your 40s. The progress of irregular menstrual patterns is natural. With Femarelle Rejuvenate, you will experience:

Better control over your decreased mood
Improved sleep
Increased energy levels
Better skin elasticity


Chief editor of ‘Climacteric’ Consultant gynecologist Chairman of the board of the IMS ” Many women choose to use non-hormonal options, but many of them are not effective. Femarelle provided for me a choice which had all the benefits of hormones, but works in a different way, minimizing the risks while maintaining the benefits.*”	Former president of the NAMS Director of Women’s Wellness Program “ I started recommending Femarelle to my patients after I visited the plant where Femarelle is manufactured and I saw that there was really great quality control... so I started using it and found it very effective... It seems to be the perfect SERM; it doesn't do the bad things that hormones can do and it seems to do the good things... I think it is very safe and effective.*"	President of the ISGE. Former IMS president. Director of OBGYN dept University of Pisa. ” Femarelle is strongly improving quality of life... Until now, no side effects have been identified... My suggestion is that the treatment is to be done for as long as possible.*”

Every woman is different, and so is her experience with symptoms in each stage of estrogen decline. That's why we designed a line of products to address your specific needs.


	Rejuvenate	Recharge	Unstoppable
Main Symptoms	MOOD, SKIN & FATIGUE	HOT FLASHES, NIGHT SWEATS & MORE	BONE, JOINTS & VAGINAL HEALTH
4 Weeks Supply 56 Capsules	✓	✓	✓
NON GMO	✓	✓	✓
NON Dairy	✓	✓	✓
Gluten FREE	✓	✓	✓

Published Studies Femarelle

Yoles I. et al. Efficacy and Safety of Standard versus Low Dose of Femarelle (Tofupill) for the Treatment of Menopausal Symptoms. J. of Clin Exper Obstet Gynecol 2004; 31(2):123-26
Labos G., Trakakis E. et al Efficacy and safety of DT56a (Femarelle) compared to hormone therapy in Greek postmenopausal women. J Endocrinol. Invest. 2013; 36(7):521-6
Genazzani AR et al. Brain region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Menopause 2009; 16(5):1037-43
Nachtigall M. et al. A Prospective Study of DT56a (Femarelle) for the Treatment of Postmenopausal Vaginal Atrophy. Menopause book of abstract of the NAMS 22nd Annual Meeting, Sept, 2011, p. 55
Yoles I. et al. Tofupill/Femarelle (DT56a) - a New Phyto-Selective Estrogen Receptor Modulator-like Substance for the Treatment of Postmenopausal Bone Loss. Menopause 2003; 10(6):522-25
Somjen D, Yoles I. DT56a (Tofupill/Femarelle), selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus. J. of Steroid Biochemistry & Molecular Biology 2003; 86(1):93-98
Somjen D. et al. DT56a (Femarelle/Tofupill) Stimulates Bone Formation in Female Rats. British J. of Obstetrics & Gynecology 2005; 112(7):981-85
Somjen D., Katzburg S. Lieberherr M., Hendel D., Yoles I. DT56a Stimulates Gender-Specific Human Cultured Bone Cells In Vitro. J. of Steroid Biochemistry & Molecular Biology 2006; 98(1):90-96
Somjen D. et al. The Effects of Native and Synthetic Estrogenic Compounds as well as Vitamin D Less-Calcemic Analogs on Adipocytes Content in Rat Bone Marrow. J Endocrinol Invest. 2011;34(2):106-10
Yoles I., and Lilling G. Pharmacological Doses of the Natural phyto-SERM DT56a (Femarelle) Have no Effect on MCF-7 Breast Cancer Cell-Line. European J. of Obstetrics & Gynecology & Reproductive Biology 2006; 130(1):140-141
Nachtigall M et al. The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women. Menopause 2011;18(3):285-288
Oropeza M.V, Orozco S, Ponce H, Campos M.G. Tofupill lacks peripheral estrogen-like actions in the rat reproductive tract. Reproductive Toxicology 2005; 20(2):261-66
Somjen D, Yoles I. DT56a (Femarelle): a Natural Selective Estrogen Receptor Modulator (SERM). J. of Steroid Biochemistry & Molecular Biology 2007;104:252-58
Somjen D. et al. DT56a (Femarelle); is effective in human derived female osteoblasts in hyperglycemic condition. J Steroid Biochem Mol Biol. 2011; 123:25-29
Bedell S., Nachtigall M., Naftolin F. The pros and cons of plant estrogens for menopause; J. Steroid Biochem. Mol. Biol. 2014;139:225-236
Sánchez-Borrego R, Mendoza N, Llaneza P. A prospective study of DT56a (Femarelle) for the treatment of menopause symptoms. Climacteric. 2015;18(6):813-6
Sánchez-Borrego R. et al. Efficacy and safety of a phyto-SERM as an alternative to hormone therapy; Climacteric. 2015 Jun;18(3):350-7
Chen FP et al. Efficacy of Femarelle for the treatment of climacteric syndrome in postmenopausal women: An open label trial. Taiwan J Obstet Gynecol. 2016 Jun; 55(3):336-40
Somjen D, Yoles I.: "DT56a stimulates creatine kinase specific activity in vascular tissues of rats. J. of Endocrinological Investigation 2003;26(10):966-971
Somjen D. et al. Interaction between the effects of the selective estrogen modulator Femarelle and a vitamin D analog in human umbilical artery vascular smooth muscle cells. J Steroid Biochem Mol Biol. 2017;174:9-13
Genazzani AR. DT56a, a non-hormonal botanical therapy, as first line treatment for menopausal symptoms. 12th European Society of Gynecology Congress, Opening Symposium - Climacteric and Menopause: from symptoms to therapies, from security to efficacy; October 18, 2017

This website follows the safe harbor principle. If any infringement, please inform us in time and we will delete it in time. About safe harbor，please click here to learn more.

After Sale Service:

1 Insurance Policy: Click to go to the Help Center to view the Insurance Policy

2 The rules apply and summit for receive compensation

3 The conditions of accrual for amount insurance

5 Damage to the parcel during international shipping, which resulted in damage to the goods in it

6 Loss of individual goods under international shipment The absence individual goods in the parcel

7 Non-compliance individual goods in color, size, complications Damage to the goods during international shipment

8 Returns Policy: Click to go to the Help Center to view the Returns Policy

All Category
All Category

Women's Clothings

Men's Clothings

Femarelle Rejuvenate Pre-Menopause Relief for Mood, Skin, Fatigue & More. Clinically Shown to Relieve Menopausal Symptoms -1 Month Supply

BEST SELLERS

Product introduction

Shipping Notices

Product Description

Rejuvenate

1 Pack (56 Capsules) = 4 Weeks Supply

If you are in your 40s, and you start to see changes in your regular menstruation patterns, Femarelle Rejuvenate is for you.

Better control over your decreased mood
Improved sleep
Increased energy levels
Better skin elasticity


Chief editor of ‘Climacteric’ Consultant gynecologist Chairman of the board of the IMS ” Many women choose to use non-hormonal options, but many of them are not effective. Femarelle provided for me a choice which had all the benefits of hormones, but works in a different way, minimizing the risks while maintaining the benefits.*”	Former president of the NAMS Director of Women’s Wellness Program “ I started recommending Femarelle to my patients after I visited the plant where Femarelle is manufactured and I saw that there was really great quality control... so I started using it and found it very effective... It seems to be the perfect SERM; it doesn't do the bad things that hormones can do and it seems to do the good things... I think it is very safe and effective.*"	President of the ISGE. Former IMS president. Director of OBGYN dept University of Pisa. ” Femarelle is strongly improving quality of life... Until now, no side effects have been identified... My suggestion is that the treatment is to be done for as long as possible.*”

Every woman is different, and so is her experience with symptoms in each stage of estrogen decline. That's why we designed a line of products to address your specific needs.


	Rejuvenate	Recharge	Unstoppable
Main Symptoms	MOOD, SKIN & FATIGUE	HOT FLASHES, NIGHT SWEATS & MORE	BONE, JOINTS & VAGINAL HEALTH
4 Weeks Supply 56 Capsules	✓	✓	✓
NON GMO	✓	✓	✓
NON Dairy	✓	✓	✓
Gluten FREE	✓	✓	✓

Published Studies Femarelle

Yoles I. et al. Efficacy and Safety of Standard versus Low Dose of Femarelle (Tofupill) for the Treatment of Menopausal Symptoms. J. of Clin Exper Obstet Gynecol 2004; 31(2):123-26
Labos G., Trakakis E. et al Efficacy and safety of DT56a (Femarelle) compared to hormone therapy in Greek postmenopausal women. J Endocrinol. Invest. 2013; 36(7):521-6
Genazzani AR et al. Brain region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Menopause 2009; 16(5):1037-43
Nachtigall M. et al. A Prospective Study of DT56a (Femarelle) for the Treatment of Postmenopausal Vaginal Atrophy. Menopause book of abstract of the NAMS 22nd Annual Meeting, Sept, 2011, p. 55
Yoles I. et al. Tofupill/Femarelle (DT56a) - a New Phyto-Selective Estrogen Receptor Modulator-like Substance for the Treatment of Postmenopausal Bone Loss. Menopause 2003; 10(6):522-25
Somjen D, Yoles I. DT56a (Tofupill/Femarelle), selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus. J. of Steroid Biochemistry & Molecular Biology 2003; 86(1):93-98
Somjen D. et al. DT56a (Femarelle/Tofupill) Stimulates Bone Formation in Female Rats. British J. of Obstetrics & Gynecology 2005; 112(7):981-85
Somjen D., Katzburg S. Lieberherr M., Hendel D., Yoles I. DT56a Stimulates Gender-Specific Human Cultured Bone Cells In Vitro. J. of Steroid Biochemistry & Molecular Biology 2006; 98(1):90-96
Somjen D. et al. The Effects of Native and Synthetic Estrogenic Compounds as well as Vitamin D Less-Calcemic Analogs on Adipocytes Content in Rat Bone Marrow. J Endocrinol Invest. 2011;34(2):106-10
Yoles I., and Lilling G. Pharmacological Doses of the Natural phyto-SERM DT56a (Femarelle) Have no Effect on MCF-7 Breast Cancer Cell-Line. European J. of Obstetrics & Gynecology & Reproductive Biology 2006; 130(1):140-141
Nachtigall M et al. The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women. Menopause 2011;18(3):285-288
Oropeza M.V, Orozco S, Ponce H, Campos M.G. Tofupill lacks peripheral estrogen-like actions in the rat reproductive tract. Reproductive Toxicology 2005; 20(2):261-66
Somjen D, Yoles I. DT56a (Femarelle): a Natural Selective Estrogen Receptor Modulator (SERM). J. of Steroid Biochemistry & Molecular Biology 2007;104:252-58
Somjen D. et al. DT56a (Femarelle); is effective in human derived female osteoblasts in hyperglycemic condition. J Steroid Biochem Mol Biol. 2011; 123:25-29
Bedell S., Nachtigall M., Naftolin F. The pros and cons of plant estrogens for menopause; J. Steroid Biochem. Mol. Biol. 2014;139:225-236
Sánchez-Borrego R, Mendoza N, Llaneza P. A prospective study of DT56a (Femarelle) for the treatment of menopause symptoms. Climacteric. 2015;18(6):813-6
Sánchez-Borrego R. et al. Efficacy and safety of a phyto-SERM as an alternative to hormone therapy; Climacteric. 2015 Jun;18(3):350-7
Chen FP et al. Efficacy of Femarelle for the treatment of climacteric syndrome in postmenopausal women: An open label trial. Taiwan J Obstet Gynecol. 2016 Jun; 55(3):336-40
Somjen D, Yoles I.: "DT56a stimulates creatine kinase specific activity in vascular tissues of rats. J. of Endocrinological Investigation 2003;26(10):966-971
Somjen D. et al. Interaction between the effects of the selective estrogen modulator Femarelle and a vitamin D analog in human umbilical artery vascular smooth muscle cells. J Steroid Biochem Mol Biol. 2017;174:9-13
Genazzani AR. DT56a, a non-hormonal botanical therapy, as first line treatment for menopausal symptoms. 12th European Society of Gynecology Congress, Opening Symposium - Climacteric and Menopause: from symptoms to therapies, from security to efficacy; October 18, 2017

Shipping Notices:

1 Contraband and limited items:

Clgarette,Alcohol,Contraband ?Do not accept

Liquid,cream or cosmetics items are quantity limited in shopping agent service

Chinese medicine is limited to ship by Chinese exporting goods.

2 Limitation for different shipping methods:

3 Yoybuy Product's Label:

Sensitive Product(SEN)

Product With battery

Cream

Powder

Dangerous Products

4 Volume weight Requested:

volume weight=length*height*Width/5000

one side must be less than 120cm，otherwise there is additional fee；250cm products can not be accept；

Any side must be less than 60cm，otherwise you will be charged the greater one between real weight and volume weight，more than 120cm will be not accepted.